Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Avanos Medical Inc (AVNS)
Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,148,008
  • Shares Outstanding, K 46,667
  • Annual Sales, $ 820,000 K
  • Annual Income, $ 50,500 K
  • 60-Month Beta 0.92
  • Price/Sales 1.41
  • Price/Cash Flow 9.06
  • Price/Book 0.88
Trade AVNS with:

Options Overview Details

View History
  • Implied Volatility 41.23% ( -10.34%)
  • Historical Volatility 56.85%
  • IV Percentile 40%
  • IV Rank 49.73%
  • IV High 76.80% on 06/13/22
  • IV Low 6.03% on 08/30/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 64
  • Open Int (30-Day) 52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.32
  • Number of Estimates 4
  • High Estimate 0.33
  • Low Estimate 0.30
  • Prior Year 0.41
  • Growth Rate Est. (year over year) -21.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.21 +12.74%
on 05/18/23
25.51 -1.84%
on 06/06/23
+1.07 (+4.46%)
since 05/05/23
3-Month
22.21 +12.74%
on 05/18/23
31.31 -20.03%
on 04/24/23
-3.80 (-13.18%)
since 03/06/23
52-Week
19.32 +29.61%
on 10/13/22
31.99 -21.73%
on 02/21/23
-2.81 (-10.09%)
since 06/06/22

Most Recent Stories

More News
Avanos (AVNS) Q1 Earnings and Revenues Fall Shy of Estimates

Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.

ISRG : 315.72 (-0.56%)
CAH : 84.34 (-0.50%)
ABC : 174.37 (-0.18%)
AVNS : 25.04 (+1.79%)
Add This Top Equipment Stock to Your Portfolio for a Strong Week Ahead

Smith & Nephew (SNN) looks poised for steady long-term growth as it focuses on its earlier outlined 12-point growth plan and strengthens its portfolio. With the stock surging in price, it could be worth...

AVNS : 25.04 (+1.79%)
OLYMY : 15.6650 (-0.44%)
SNN : 30.29 (+0.03%)
UTMD : 96.45 (+3.42%)
Here's Why You Should Retain Exact Sciences (EXAS) Stock Now

Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.

HOLX : 79.04 (unch)
BIO : 370.78 (+0.59%)
EXAS : 85.22 (+0.32%)
AVNS : 25.04 (+1.79%)
Avanos Medical (AVNS) Q1 Earnings and Revenues Lag Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -3.57% and 1.54%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 25.04 (+1.79%)
TCMD : 24.23 (+1.42%)
Avanos Medical, Inc. Announces First Quarter 2023 Results

/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2023 financial results. "Our first quarter results were mixed, with our...

AVNS : 25.04 (+1.79%)
Here's Why You Should Retain National Vision (EYE) Stock Now

National Vision's (EYE) share price is likely to grow following the company's efforts to expand remote capabilities and investments in doctor recruiting and retention efforts.

EYE : 26.18 (+1.16%)
BSX : 50.67 (-1.42%)
PODD : 285.56 (+0.52%)
AVNS : 25.04 (+1.79%)
Here's Why You Should Retain Neogen (NEOG) Stock for Now

Investors are optimistic about Neogen (NEOG) owing to strong performance across its Animal Safety and Food Safety segments.

BDX : 250.46 (-1.39%)
HOLX : 79.04 (unch)
NEOG : 19.14 (+4.02%)
AVNS : 25.04 (+1.79%)
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.

DGX : 133.15 (-0.80%)
HSIC : 75.37 (+0.15%)
BIO : 370.78 (+0.59%)
AVNS : 25.04 (+1.79%)
Integra's (IART) Q1 Earnings Match Estimates, Margins Contract

In CSS, Integra (IART) witnesses a good start to the year with double-digit growth in the CUSA product line and programmable valves as well as strong performance in instrument sales.

IART : 40.67 (+2.60%)
HSIC : 75.37 (+0.15%)
BIO : 370.78 (+0.59%)
AVNS : 25.04 (+1.79%)
Align Technology (ALGN) Q1 Earnings Beat, Margins Contract

Align Technology (ALGN) delivers better-than-expected revenues and earnings in the first quarter of 2023 but suffers significant foreign currency woes.

ALGN : 304.68 (-0.15%)
HSIC : 75.37 (+0.15%)
PODD : 285.56 (+0.52%)
AVNS : 25.04 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.

See More

Key Turning Points

3rd Resistance Point 26.41
2nd Resistance Point 25.96
1st Resistance Point 25.50
Last Price 25.04
1st Support Level 24.59
2nd Support Level 24.14
3rd Support Level 23.68

See More

52-Week High 31.99
Fibonacci 61.8% 27.15
Fibonacci 50% 25.65
Last Price 25.04
Fibonacci 38.2% 24.16
52-Week Low 19.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar